NEW YORK, March 18, 2014 /PRNewswire/ --

On Monday, March 17, 2014, the NASDAQ Composite finished at 4,279.95, up 0.81%. The Dow Jones Industrial Average closed the session at 16,247.22, up 1.13% and the S&P 500 ended the day at 1,858.83, higher by 0.96%. The gains were broad based as all the sectors ended the session in positive. Investor-Edge.com looks at some of the equities that hit a new 52-week high during the last session. These include NextEra Energy Inc. (NYSE:NEE), Silver Standard Resources Inc. (NASDAQ:SSRI), Wisconsin Energy Corporation (NYSE MKT: WEC), and Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Free research on these four companies can be accessed at:

http://investor-edge.com/register

On Monday, NextEra Energy Inc.'s stock closed at $94.81, up 0.58%, hitting a new 52-week high of $95.07. The stock recorded a trading volume of 1.82 million shares, compared with the three-month average volume of 2.11 million shares. NextEra Energy Inc.'s shares were traded at a PE ratio of 19.13 and were up 10.73% on YTD basis. Shares of the company have advanced 2.84% in the past three trading sessions and surged 14.74% in the last three months. The stock has witnessed a gain of 1.65% in the last one month. The S&P 500 Utilities sector Index mapped a gain of 0.62% during the session while the same has charted up by 9.41% during the last three months. The stock is trading above its 50-day and 200-day moving averages. NextEra Energy Inc.'s 50-day moving average of $89.80 is above the 200-day moving average of $84.49. Moreover, the company's shares were trading at the Relative Strength Index (RSI) of 65.53. Sign up and read the free notes on NEE at:

http://www.Investor-Edge.com/03182014/NEE/report.pdf

Silver Standard Resources Inc.'s stock fluctuated in the range of $11.37 and $12.21 during Monday's session, hitting a new 52-week high of $12.21. The stock reported a loss of 1.64%, ending the day at $11.38. A total of 5.19 million shares were traded, which is above the 3-month average volume of 1.95 million shares. The company's shares have surged 10.16% in the last one month and 64.93% in the previous three months. The S&P 500 Materials sector Index posted gains of 2.39% in the last one month and 6.65% in the previous three months. The company's shares have advanced 63.51% on YTD basis. The company's shares are trading above their 50-day and 200-day moving averages of $9.09 and $7.38, respectively. The stock's RSI stood at 71.89. The complimentary notes on SSRI can be downloaded as in PDF format at:

http://www.Investor-Edge.com/03182014/SSRI/report.pdf

On Monday, shares in Wisconsin Energy Corp. edged 0.77% higher to finish the day at $45.66, hitting a new 52-week high of $45.87. The stock recorded a trading volume of 1.08 million shares, compared with the three-month average volumes of 1.65 million shares during the Monday's session. The company's shares traded at a PE ratio of 18.19 and were up 10.45% on YTD basis. Shares of Wisconsin Energy Corp. have advanced 4.68% in the last one month and 11.91% in the previous three months. The S&P 500 Utilities sector Index mapped a gain of 0.62% during the session and the same has advanced 9.41% during the last three months. The stock is trading above its 50-day and 200-day moving averages of $42.54 and $41.72, respectively. Furthermore, the company's shares were trading at the Relative Strength Index (RSI) of 70.89. Register for free on Investor-Edge and access the latest research on WEC at:

http://www.Investor-Edge.com/03182014/WEC/report.pdf

Shares in Vanda Pharmaceuticals Inc. finished Monday's session at $18.03, reporting a 2.15% gain after hitting new 52-weeks high of $18.48. A total of 0.64 million shares were traded, as compared to the three months average volume of 1.17 million shares. The company's stock traded between $17.74 and $18.48 during the trading session. The company's shares have surged 33.95% in the last one month and 64.66% in the previous three months. Vanda Pharmaceuticals Inc.'s stocks have advanced 45.29% on YTD basis. The S&P 500 Health Care sector Index mapped a gain of 0.91% during the session and charted up by 9.89% during the previous three months. The stock is trading above its 50-day and 200-day moving averages. The company's 50-day moving average of $13.53 is above the 200-day moving average of $11.07. The RSI of Vanda Pharmaceuticals Inc. stood at 74.37. The complete research on VNDA is available for free at:

http://www.Investor-Edge.com/03182014/VNDA/report.pdf

About Investor-Edge.com

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES:

============= 


        
        - This is not company news. We are an independent source and our views do
          not reflect the companies mentioned.
        - Information in this release is fact checked and produced on a best efforts
          basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human
          and are prone to make mistakes. If you notice any errors or omissions, please notify
          us below.
        - This information is submitted as a net-positive to companies mentioned, to
          increase awareness for mentioned companies to our subscriber base and the investing
          public.
        - If you wish to have your company covered in more detail by our team, or wish
          to learn more about our services, please contact us at pubco [at] Investor-edge.com.
        - For any urgent concerns or inquiries, please contact us at compliance [at]
          Investor-edge.com.
        - Are you a public company? Would you like to see similar coverage on your
          company? Send us a full investors' package to research [at] Investor-edge.com for
          consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

http://www.Investor-Edge.com

SOURCE Investor-Edge